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PObjective: Patients receiving mechanical ventilation through an endotracheal tube are
at increased risk for pneumonia. Because microaspiration of contaminated supraglot-
tic secretions past the endotracheal tube cuff is considered to be central in the patho-
genesis of ventilator-associated and postoperative pneumonia, better sealing of the
upper trachea by the endotracheal tube cuff could possibly reduce this risk. We there-
fore postulated that use of a polyurethane cuffed tube would prevent early postoper-
ative pneumonia through this mechanism in a population of cardiac surgical patients.
Methods: In a prospective, single-blind, randomized study, patients scheduled for
cardiac surgery were allocated to intubation with a polyurethane cuffed endotracheal
tube or the routinely used polyvinyl chloride cuffed endotracheal tube. Patients were
scheduled for routine or emergency cardiac surgery and admitted to an 8-bed cardiac
surgical intensive care unit of a tertiary care hospital.
Results: A total of 134 patients were available for analysis (67 in each group).
Whereas mortality was not different between the groups, the incidence of early post-
operative pneumonia and empirical prescription of antibiotic therapy were signifi-
cantly lower in the polyurethane group than in the polyvinyl chloride group (23%
vs 42%, P, .03). Intensive care unit and hospital stays were not significantly differ-
ent between the two study subsets (3 6 5 days vs 3 6 4 days and 16 6 9 vs 17611
days, respectively). In a multivariate regression analysis, preoperative serum creati-
nine levels (odds ratio 1.85, confidence interval 1.02–3.37, P5 .04) and perioperative
transfusion (odds ratio 1.50, confidence interval 1.08–3.37, P5 .015) were indepen-
dently associated with increased risk of early postoperative pneumonia, whereas use
of a polyurethane endotracheal tube was protective (odds ratio 0.31, confidence inter-
val 0.13–0.77, P 5 .01).
Conclusion: Polyurethane cuffed endotracheal tubes can reduce the frequency of early
postoperative pneumonia in cardiac surgical patients.
N
osocomial pneumonia is responsible for major infection-related mortality and
morbidity in the intensive care unit (ICU).1-5 As much as 50% of attributable
mortality has been reported, depending on case mix and appropriateness of
early antibiotic therapy, and attributable morbidity is reflected by an excess ICU stay
of 5 to 9 days.4 Moreover, clinically suspected nosocomial pneumonia is an important
driver of antibiotic prescription, and consequently of selection pressure on ICU micro-
bial flora.6-8 The risk of nosocomial pneumonia in critically ill patients increases 3- to
20- fold if they receive mechanical ventilation through an endotracheal tube (ET) or
cannula.1,9 Microaspiration of contaminated upper airway secretions along leaks and
defects of the tracheal seal of the cuff is assumed to play a pivotal role in the develop-
ment of intubation-related (ventilator-associated and postoperative) pneumonia.10-12
Advances in polymeric technology have permitted the development of a new generation
of polyurethane (PU) cuffed ET. It was hypothesized that a better tracheal seal would
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result from fewer folds and bends in the thinner cuff material,
and thus microaspiration of potentially contaminated upper
airway material could be reduced,13 theoretically leading to
a lower incidence of pneumonia in intubated patients.
Cardiac surgical patients represent an important subset of
patients at risk for postoperative pneumonia because of the
universal and unavoidable application of invasive mechani-
cal ventilation in supine positioning, the frequent use of intra-
operative transesophageal echocardiography (promoting
gastroesophageal regurgitation), and the systemic inflamma-
tory response syndrome induced by surgical trauma. Respira-
tory infection is estimated to complicate the postoperative
course of 5% to 20%of cardiac surgical patients.14-16 Because
postoperative and ventilator-associated pneumonia have been
identified as predictors of worse outcome in this particular pa-
tient category, strategies to prevent these pulmonary infec-
tions are strongly advocated. We assessed the potentially
preventive role of PU cuffed ETs in the development of early
postoperative pneumonia in a cohort of cardiac surgical
patients in a single-blind, randomized, controlled trial.
Materials and Methods
Study Design
A prospective, single-blind, randomized trial was conducted. Pa-
tients scheduled for cardiac surgery were randomly assigned to
receive PU (Sealguard; Covidien, Mansfield, Mass) or a standard
polyvinyl chloride (PVC; Mallinckrodt Inc, Hazelwood, Mo)
high-volume, low-pressure cuffed ET at induction of anesthesia.
Cuff volumes were comparable for the two cuff types. The attending
ICU physician providing postoperative care, as well as the investi-
gator collecting patient data and the microbiologist, were blinded
to the assignment of ET type. Once positioned in the patient, both
ET tubes were completely comparable in appearance, even to the
trained eye. The study was approved by the institutional review
board of the Ghent University Hospital, and all patients gave written
informed consent.
Patients and Procedures
All patients scheduled for routine cardiac surgery or undergoing ur-
gency or emergency cardiac surgery in the postoperative cardiac sur-
gical ICU at our tertiary referral center were eligible for the study.
Patients with pneumonia before surgery, with infectious endocardi-
tis, or with current antibiotic therapy were excluded. Randomization
occurred according to a computer-generated list, which was kept by
the attending anesthesiologists, blinded for the intensivists. Female
patients routinely received an ET with 8-mm internal diameter size,
whereas male patients were intubated with a 9-mm internal diameter
ET, although the final decision was left to the discretion of the
attending physician.772 The Journal of Thoracic and Cardiovascular Surgery c ApImmediately after endotracheal intubation and after closure of
the sternum, cuff pressure was assessed by the attending anesthe-
siologist. Care was taken to maintain cuff pressures between 20
and 26 cm H2O in both subsets. Intraoperative antibiotic prophy-
laxis consisted of cefazolin (2 g every 8 hours for 24 hours) in all
cases.
After cardiac surgery, patients were transferred to the 8-bed car-
diac surgical ICU for postoperative care and weaning from mechan-
ical ventilation. Sedation was continued with propofol (0.5–2 mg/
[kg $ h] intravenously) as previously discussed.17 All patients re-
ceived standard antacids with intravenous ranitidine (50 mg three
times daily). Only vasoactive drugs like nitrates and sometimes iso-
topic drugs were administered. Cuff pressure was measured imme-
diately on arrival and subsequently each 4 hours until extubation in
all cases. Again, cuff pressures were monitored by attending nurses
and carefully maintained between 20 and 26 cm H2O. Criteria for
weaning and extubation included stable cardiovascular dynamics
and metabolism, chest tube drainage less than 1 mL/(kg $ h) for at
least 2 consecutive hours, adequate gas exchange (defined as PaO2
.70 mm Hg with inspired oxygen fraction #0.6, peak inspiratory
pressure below 20 cm H2O, and peak end-expiratory pressure below
6 cm H2O), and adequate neurologic activity.
18 Antibiotic prophy-
laxis consisted of cefazolin (100 mg/[kg $ d]) and lasted 24 hours.
Screening and Diagnosis
After admission to the ICU, patients were screened daily for postop-
erative nosocomial pneumonia by the attending ICU physician, who
was blinded to the ET tube allocation. Diagnosis of postoperative
nosocomial pneumonia was defined before onset of the study. Be-
cause in our patient population microbial pathogens other than com-
mensal flora are rarely isolated in this setting of early postoperative
pneumonia, we aimed for higher specificity in our clinical diagnosis
by requiring that all Johanson criteria,19 as well as two additional
criteria, be fulfilled.20 Thus postoperative nosocomial pneumonia
was defined as the presence of a new or evolving infiltrate on chest
radiography within 7 days after surgery, together with the presence
of all Johanson criteria19: temperature greater than 38.2C, leukocy-
tosis greater than 12,000 cells/mm3, and presence of purulent spu-
tum or endotracheal aspirate. Additional criteria were an increase
in C-reactive protein for at least 2 consecutive days after surgery
and a deterioration in the ratio of PaO2 to inspired oxygen fraction
of at least 20%. Diagnosis was made during the stay in the ICU
by the attending intensivist, who was blinded to the assigned ET.
Oropharyngeal and endotracheal aspirates were taken on ICU ad-
mission and on clinical suspicion of pneumonia. Microbial evalua-
tion consisted of direct Gram staining and semiquantitative culture.
As such, the initiation of antibiotic therapy was left to the discretion
of the attending staff ICU physician. At our ICU, surveillance cul-
tures are used to guide empirical antibiotic therapy in cases of sus-
pected pneumonia.21,22 In the absence of surveillance cultures,
empirical therapy for early (within 7 days after ICU admission) post-
operative or ventilator-associated pneumonia without previous anti-
biotic exposure consists of cefuroxime or amoxicillin (INN
amoxicilline) and clavulanate, with an antipseudomonal betalactam
if pneumonia develops after 7 days or after previous antibiotic expo-
sure. This empirical scheme is modified accordingly if surveillance
cultures show the presence of multidrug-resistant organisms such as
extended-spectrum b-lactamase–carrying Enterobacteriaceae or
methicillin-resistant Staphylococcus aureus.ril 2008
Poelaert et al Cardiopulmonary Support and PhysiologyTABLE 1. Characteristics and outcomes of patients intubated with polyurethane versus polyvinyl chloride cuffed
endotracheal tubes
Polyvinyl (n 5 67) Polyurethane (n 5 67) P value (univariate)
Age (y, mean 6 SD) 67 6 11 68 6 9 .70
Sex (male/female ratio) 45:22 40:27 .47
Body mass index (kg/m2, mean 6 SD) 27 6 5 27 6 4 .38
Ejection fraction (%, mean 6 SD) 60 6 17 65 6 16 .10
Tu score (mean 6 SD) 4 6 3 4 6 3 .58
EuroSCORE (mean 6 SD) 5 6 4 5 6 4 .38
Duration of surgery (min, mean 6 SD) 265 6 60 247 6 64 .10
Duration of ventilation (h, mean 6 SD) 25 6 36 19 6 13 .22
Emergency surgery (No.) 18 15 .78
Packed red blood cells transfused (units, mean 6 SD) 1 6 2 1 6 1 .20
Early postoperative pneumonia (No.) 28 (42%) 15 (23%) .026
Intensive care unit stay (d, mean 6 SD) 3 6 4 3 6 5 .87
Hospital stay (d, mean 6 SD) 17 6 11 16 6 9 .53CS
PVariables Recorded and Calculated
Two scoring systems were used, EuroSCORE23,24 and Tu
score.25,26 Preoperative serum creatinine level and requirement for
blood transfusion during or immediately after surgery (within 48
hours) were recorded. The primary end point was the occurrence
of pneumonia within 3 days of cardiac surgery, considered to repre-
sent early postoperative pneumonia.
Statistical Analysis
The study was performed in two parts. A first, smaller part (n5 30)
allowed calculation of statistical power analysis (power .80, type II
error .05), yielding a target sample size of 120 patients.
Data are expressed as mean6 SD. Continuous variables were as-
sessed with ANOVA and when appropriate with an independent
t test. Categorical variables were analyzedwith the c2 test. Backward
stepwise logistic regression analysis was performed to elucidate in-
terfering factors for development of early postoperative pneumonia.
To avoid spurious associations, only variables with a plausible rela-
tionship to the development of pneumonia or variables with a rela-
tionship in univariate analysis (P 5 .20) were entered into the
model. Statistical analyses were executed with the SPSS version
10 software package (SPSS Inc, Chicago, Ill).
Results
One hundred thirty-six patients (67 in the PU group and 69 in
the PVC group) were enrolled in the study. Two patients in
the PVC group died during surgery of refractory cardiogenic
shock and were excluded from further analysis. Characteris-
tics of patients are detailed in Table 1. No differences be-
tween the two groups were found with respect to age, body
mass index, sex ratio, time on cardiopulmonary bypass, aor-
tic crossclamp time, EuroSCORE, mean duration of mechan-
ical ventilation, mortality, or length of stay in the ICU (Table
1). Early postoperative pneumonia was more frequently diag-
nosed in patients assigned to the PVC arm (28 [42%] vs 15
[23%], P5 .026); the relative risk on postoperative pneumo-
nia associated with PU use was 0.42 (0.20–0.89). No statisti-The Journal of Thorcal difference was found between the two groups with regard
to length of stay in the ICU or in the hospital (3 6 4 days in
the PVC group versus 36 5 days in the PU subset and 176
11 days vs 16 6 9 days, respectively). Table 2 shows no
difference in frequency of the different types of surgical
interventions.
Outcome Measures
Characteristics and outcomes in patients with and without di-
agnosis of early postoperative pneumonia are shown in Table
3. Patients with pneumonia had a similar mortality to that of
patients without pneumonia but significantly longer ICU and
hospital stays (56 7 days vs 26 1 days, P5 .003, and 216
15 days vs 146 6 days, P5 .004, respectively). No patients
required reintubation. Other potentially influencing factors
are listed in Table 4. Microbial etiology of early postopera-
tive pneumonia was documented in 15 cases (Table 5); all
pathogens were susceptible to instituted empirical antibiotic
therapy, which consisted of cefuroxime for 5 to 7 days.
To correct for imbalances between the patient groups as-
signed to PU versus PVC that might confound the association
TABLE 2. Surgical comparison of patients intubated with
polyurethane versus polyvinyl chloride cuffed endo-
tracheal tubes
Polyvinyl
(n 5 67)
Polyurethane
(n 5 67)
Coronary artery bypass grafting 37 37
Combined
Coronary artery bypass
grafting 1 valve
14 12
$1 valve 0 1
Single-valve surgery 16 15
Aortic surgery 0 2
No statistically significant difference between the two groups was seen.acic and Cardiovascular Surgery c Volume 135, Number 4 773
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CSPTABLE 3. Characteristics and outcomes of patients with and without early postoperative pneumonia
Pneumonia (n 5 43) No pneumonia (n 5 91) P value (univariate)
Age (y, mean 6 SD) 70 6 9 66 6 10 .025
Sex (male/female ratio) 28:15 54:35 .763
Ejection fraction (%, mean 6 SD) 58 6 18 64 6 16 .038
Body mass index (kg/m2, mean 6 SD) 32 6 2 27 6 5 .216
Creatinemia (mg/dL) 1.6 6 1.5 1.1 6 0.5 .035
Tu score (mean 6 SD) 5 6 3 3 6 3 .034
EuroSCORE (mean 6 SD) 7 6 4 4 6 3 .001
Duration of surgery (min, mean 6 SD) 256 6 75 257 6 57 .944
Duration of ventilation (h, mean 6 SD) 31 6 45 18 6 11 .052
Packed red blood cells (units, mean 6 SD) 2 6 2 1 6 1 .010
Polyurethane tube present (No.) 15 (35%) 50 (56%) .026
ICU stay (d, mean 6 SD) 5 6 7 2 6 1 .003
Hospital stay (d, mean 6 SD) 21 6 15 14 6 6 .004between ET type and early postoperative pneumonia, a multi-
variate analysis was performed (Table 6). In backward step-
wise logistic regression, elevated preoperative serum
creatinine level (odds ratio 1.85, confidence interval 1.02–
3.37, P 5 .04) and perioperative transfusion (odds ratio
1.50 per unit of packed cells required, confidence interval
1.08–3.37, P5 .015) were independently associated with in-
creased risk of early postoperative pneumonia, whereas allo-
cation to the PU group was associated with a lower risk (odds
ratio 0.31, confidence interval 0.13–0.77, P 5 .01; Table 6).
Discussion
In this randomized, controlled trial, use of a PU cuffed ET
during cardiac surgery was associated with a roughly 50%
decrease in early postoperative pneumonia. To the best of
our knowledge, this is the first study to demonstrate a protec-
tive effect from the use of a PU cuffed tube against the devel-
opment of early postoperative pneumonia in clinical practice.
Because nosocomial pneumonia has been identified as an
TABLE 4. Frequencies of preoperative risk factors that could
facilitate the development of postoperative pneumonia
Pneumonia
present
Pneumonia
absent
Variable
PVC
(n 5 39)
PU
(n 5 52)
PVC
(n 5 28)
PU
(n 5 15)
Reoperation 2 3 2 3
Intra-aortic balloon pump 5 4 7 4
Diabetes 9 15 8 7
Chronic obstructive
pulmonary disease
5 8 2 1
Pulmonary hypertension 7 6 8 3
Tobacco use 19 17 13 3
Chronic renal failure 7 11 11 6
No statistically significant differenceswere seen (P2 test).PU,Polyurethane
cuffed endotracheal tube; PVC, polyvinyl chloride cuffed endotracheal tube.774 The Journal of Thoracic and Cardiovascular Surgery c Aprindependent risk factor for mortality through development
of multiple organ failure, both in the general ICU popula-
tion1,4,7,22 and in postoperative cardiac surgical patients in
particular,15,16,27 the importance of preventive strategies can-
not be overestimated. Whenever a pneumonia was present,
independently of the tube used, increased lengths of stay
(both ICU and hospital) were observed (Table 3). With
regard to the two subsets of patients, however, no overall
difference of length of stay in the ICU or the hospital could
be shown (Table 1).
Prevention of early postoperative pneumonia is to be
achieved through a multimodality and multidisciplinary
effort.11,28 Strategies to disrupt the sequence of oral coloniza-
tion with pathogenic organisms, followed by dislocation of
this contaminated material into the lower airways through de-
fective upper airway barriers and subsequent development of
tracheobronchitis and ultimately pneumonia, however, play
a central role in each preventive program. Semirecumbent
positioning, rather than supine positioning, of ventilated pa-
tients (especially when enterally fed) has been conclusively
shown to decrease the risk of early postoperative and ventila-
tor-associated pneumonia, as has to a lesser extent the prac-
tice of continuous suctioning of subglottic secretions.28,29
TABLE 5. Bacteria isolated from tracheal aspirates (thresh-
old at least 105 colony-forming units/mL)
Polyurethane
(n 5 67)
Polyvinyl
(n 5 67)
Negative cultures 11 16
Commensal flora 2 6
Escherichia coli 1 1
Pseudomonas aeruginosa 1 1
Serratia species 0 1
Klebsiella species 0 1
Citrobacter species 0 1
Enterobacter species 0 1il 2008
Poelaert et al Cardiopulmonary Support and PhysiologyTABLE 6. Multivariable regression analysis (backward stepwise) of factors associated with diagnosis of early ventilator-
associated pneumonia (n 5 129)
Predictor Parameter estimate Odds ratio Confidence interval P value
Preoperative serum creatininemia 0.62 1.85 1.02-3.37 .04
Units transfused of packed red blood cells 0.41 1.50 1.08-3.37 .015
Polyurethane cuffed endotracheal tube 21.17 0.31 0.13-0.77 .01
Constant 21.5
Parameters included were as follows: EuroSCORE, duration of mechanical ventilation, preoperative serum creatininemia, units of perioperatively transfused
packed blood cell, use of polyurethane cuffed endotracheal tube. Hosmer–Lemeshow goodness of fit,P2 8 P5 .92, area under receiver operating curve 0.736 0.05.CS
PA recent multicenter trial reported reduced lower bacterial
airway colonization associated with the use of a silver-coated
ET, probably through the topical antimicrobial effect of silver
ions, although a reduction in prevalence of subsequent pneu-
monia was not observed.30 From this perspective, decreasing
leakage of contaminated upper airway secretions through
folds and channels between (partially) inflated ET cuffs and
tracheal wall can be considered as part of the central core
of preventive measures, especially in circumstances where
semirecumbent positioning is not possible, such as during
cardiac surgery. Altering the material of the cuff from PVC
to PU permits a thinner cuff wall, which therefore expands
more completely and follows internal diameter of the trachea
more closely when the cuff is inflated.13
Table 6 discloses that the type of ET tube was a stronger
predictor than either the number of packed red cell units
transfused or preoperative renal function. In a large retrospec-
tive study on risk factors for postoperative infection in car-
diac surgery, blood bank requirements, among many other
factors, were associated with postoperative infection risk.31
and Corwin and associates32 identified transfusion as an inde-
pendent risk factor for ventilator-associated pneumonia in
a general ICU population. Insofar as transfusion policy is
dependent on predefined transfusion thresholds, rather than
reflecting perioperative complications, this may prove to be
a modifiable risk factor as well. Nevertheless, prevention of
postoperative pneumonia appears to be far more important.
Some drawbacks and shortcomings of this investigation
should be mentioned. Amajor flaw of this investigation could
be the lack of microbiologic confirmation of most episodes of
postoperative pneumonia. This may in part have been due to
the postoperative setting in which this study was conducted.
All patients received intraoperative antibiotic prophylaxis
(with a first-generation cephalosporin), which probably has
prevented subsequent isolation of microbial pathogens caus-
ing early-onset pneumonia, because these are known to be re-
flective of patients’ endogenous flora rather than potentially
multidrug-resistant nosocomial flora. In addition, because
most patients were already extubated when pneumonia was
considered clinically likely, part of this low yield may have
been caused by difficulties in obtaining a good quality lower
airway microbiologic sample. Alternatively, because a clini-
cal diagnosis of nosocomial pneumonia suffers from lack ofThe Journal of Thospecificity,19 it could be argued that some of the episodes of
postoperative pneumonia were in fact noninfectious compli-
cations mimicking pneumonia, such as aspiration pneumoni-
tis, acute lung injury, or atelectasis. Clearly, there is need for
more discriminative diagnostic tests for nosocomial pneumo-
nia, in particular ventilator-associated pneumonia, to reduce
unnecessary antibiotic therapy. Because invasive micro-
biologic sampling was not judged feasible for our fragile,
recently extubated patient population, and additional
diagnostic tests such as procalcitonin are not yet validated
for nosocomial pneumonia33 and were not available to us,
a clinical diagnosis of pneumonia was the best we could
offer. Moreover, this clinically based diagnosis is reflective
of widespread clinical practice, with additional variables in-
creasing specificity to 92%.20,34 It is important to mention
that our ICU physicians responsible for postoperative care,
including diagnosis and antibiotic treatment of likely pneu-
monia, were blinded to the patient allocation.
At the very least, our study shows that use of a PU cuffed
tube is able to decrease early postoperative antibiotic pre-
scription by half. This reduction may have a favorable effect
indirectly, because empirical postoperative antibiotic therapy
itself has been found to increase the risk for nosocomial in-
fection in cardiac surgical patients.35 Our results may not
be readily extrapolated to the general ICU population. All
our patients were intubated in the setting of anesthetic induc-
tion for cardiac surgery, so risk for significant aspiration dur-
ing this procedure was kept to a minimum. In an unplanned or
emergency resuscitation, significant aspiration of oropharyn-
geal content into the lower airways may happen before or
during airway intubation, diminishing the preventive effect
of a tighter tracheal seal once the ET is in place. Because
the duration of mechanical ventilation in our patients was
short, it has yet to be established whether a PU cuffed ET
would limit endotracheal microaspiration during prolonged
mechanical ventilation.
Another issue might be that some results are skewed, in
particular with respect to ejection fraction and surgery dura-
tion (Table 1). A clinical difference was nonexistent, how-
ever, and the presence of comparable scoring indices could
preclude this potential impact.
In conclusion, use of a PU cuffed ET instead of a standard
PVC cuffed ET during cardiac surgery could significantlyracic and Cardiovascular Surgery c Volume 135, Number 4 775
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CSPdecrease the occurrence of clinically suspected pneumonia in
the early postoperative phase and subsequently reduce the
use of empirical antibiotic therapy. A larger randomized trial
is desirable to confirm this finding and to examine whether it
holds true when a more rigid, microbiologically centered di-
agnosis of pneumonia is applied. In the absence of a reliable
diagnostic strategy for ventilator-associated pneumonia or
postoperative pneumonia, however, use of a PU cuffed ET
in cardiac surgery can still be advocated as an antibiotic-
reducing and cost-effective strategy.
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